Phase III Study of DCVAC Added to Standard Chemotherapy for Men With Metastatic Castration Resistant Prostate Cancer
Status:
Recruiting
Trial end date:
0000-00-00
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether DCVAC/PCa added onto Standard of Care
Chemotherapy can improve survival times for patients with Metastatic Castration Resistant
Prostate Cancer.